Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X CleanTech (CTEC) vs Moderna, Inc. (MRNA) Price & Performance

Global X CleanTechTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Global X CleanTech vs Moderna, Inc. — how do they compare? Global X CleanTech trades at $60.24, while Moderna, Inc. trades at $62.24 (market cap $24.18B). The key difference: Moderna, Inc. is trading nearer its 52-week high, Global X CleanTech nearer its low. Which is the better fit depends on your goals.

CTECMRNA
Sector
Sector/ThematicHealth
52-Week High
$78.11$81.80
52-Week Low
$41.08$22.36
Market Cap
$24.18B
Enterprise Value
$20.33B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X CleanTech

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $59.81, up 1.08% today, with a bullish technical signal from moving averages and recent FDA approval for its mRNA flu vaccine mFLUSIVA. Despite beating Q2 2026 EPS estimates, revenue has declined from pandemic peaks, with a net income margin of -142.58% in 2026. The stock faces resistance near $61-$63, while support lies at $56-$59.

Outlook remains mixed; pipeline advancements in flu, Ebola, and oncology offer growth potential, but persistent losses and high valuation ratios pose risks. Analyst consensus is cautious with a $54.33 price target below current levels, reflecting concerns over profitability amid transitioning business focus.

Returns comparison

Trailing returns across standard periods

About Global X CleanTech

CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.

Read more on CTEC

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA